Received Mar 17, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Patient received 1st dose on 29-AUG-2025 and didn't get the 2nd dose till now; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a elderly female patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (Patient received first dose on a 29-AUG-2025 without batch number and expiry date). The patient did not receive the 2nd dose of Twinrix. The patient experienced incomplete course of vaccination (Verbatim: Patient received 1st dose on 29-AUG-2025 and didn't get the 2nd dose till now). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 12-MAR-2026 The batch number was not provided upon follow up with the reporter.